<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-147412" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Phosgene Toxicity</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Von Zimmerman</surname>
            <given-names>Matthew A.</given-names>
          </name>
          <aff>Louisiana State University Shreveport</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Arnold</surname>
            <given-names>Thomas C.</given-names>
          </name>
          <aff>LSU Health - Shreveport</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Matthew Von Zimmerman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Thomas Arnold declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>12</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-147412.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Phosgene is a hydrophobic, gaseous pulmonary irritant ubiquitous in today's industrial landscape as a chemical intermediate. Its toxicity ranges from mild irritation to severe pulmonary edema, and no antidote or reversal agent exists at this time. Despite its widespread use, some regions poorly regulate its production, and concern exists for its potential as a weapon of bioterrorism, making it a topic of interest. Given its severe toxicity and high mortality, research is primarily limited to animal studies and case series. The article presents the background of phosgene, its pathophysiology, characteristic historical and physical features, and proposed management strategies required by inter-professional team members.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Determine&#x000a0;the pathophysiology of phosgene toxicity.</p></list-item><list-item><p>Identify&#x000a0;current management strategies for phosgene toxicity.</p></list-item><list-item><p>Identify key elements of history and physical that are characteristic of acute phosgene toxicity.</p></list-item><list-item><p>Communicate&#x000a0;differential diagnoses and how to distinguish them from phosgene toxicity.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=147412&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=147412">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-147412.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Phosgene dates back over 200 years to its conception in the laboratory of Cornish chemist John Davy. During WWI, it was known as 'Choky Gas' or 'CG.'<xref ref-type="bibr" rid="article-147412.r1">[1]</xref>&#x000a0;Today, it remains ubiquitous in the industrial landscape. Phosgene is a hydrophobic, volatile irritant that causes chemical pneumonitis and is a cause of acute respiratory distress syndrome (ARDS) that can be refractory.</p>
      </sec>
      <sec id="article-147412.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Current research is directed toward phosgene's potential as a bioterrorism weapon in industrial settings where phosgene production is unregulated. Phosgene exists in the gaseous phase at room temperature but may be stored in the liquid phase below 8.2 degrees Celsius. Global estimates indicate more than 12 million metric tons of this chemical are produced annually.<xref ref-type="bibr" rid="article-147412.r2">[2]</xref>&#x000a0;</p>
        <p>Stratified by country, China produces 37% of the world's phosgene, followed by Europe (31%) and North America (20%). Recently, the Environmental Protection Agency (EPA) identified 123 sites in the United States that could expose millions of people to phosgene if the plant malfunctions or becomes a target of bioterrorism. Phosgene is denser than air, and thus, during exposure, it can be expected to accumulate in low-lying, poorly ventilated, or enclosed regions.<xref ref-type="bibr" rid="article-147412.r2">[2]</xref><xref ref-type="bibr" rid="article-147412.r3">[3]</xref>&#x000a0;</p>
        <p>Characteristically, phosgene has a distinct odor. Reports have described it as musty or similar to freshly mowed grass or hay. However, only 10% of the population may appreciate this odor at concentrations reaching 2 ppm. The combination of its unassuming odor and poor human detection makes phosgene particularly dangerous.<xref ref-type="bibr" rid="article-147412.r4">[4]</xref></p>
      </sec>
      <sec id="article-147412.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Historically used in military settings, phosgene today is a chemical intermediate in dye production, pesticides, livestock feed chemicals, pharmaceuticals, and organic intermediates.<xref ref-type="bibr" rid="article-147412.r5">[5]</xref>&#x000a0;It may also be released as a byproduct during chemically induced paint decomposition or welding fumes.<xref ref-type="bibr" rid="article-147412.r6">[6]</xref>&#x000a0;</p>
        <p>Victims exposed to a large house fire or industrial fires are also at risk of phosgene poisoning due to the combustion of chlorinated products. There is a paucity of current epidemiologic data about phosgene toxicity. Reports are limited to anecdotes, case studies, simulations, and estimations.</p>
      </sec>
      <sec id="article-147412.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Phosgene's lone carbonyl group makes it a highly reactive molecule.<xref ref-type="bibr" rid="article-147412.r7">[7]</xref>&#x000a0;Phosgene reacts with surfactant and other functional groups in the lower respiratory epithelium. Modern theories of phosgene toxicity propose that the carbonyl group reacts with primary amine, hydroxide, and mercapto groups, leading to cellular breakdown and reactive oxygen species, which deplete pulmonary glutathione stores.<xref ref-type="bibr" rid="article-147412.r7">[7]</xref><xref ref-type="bibr" rid="article-147412.r8">[8]</xref>&#x000a0;</p>
        <p>The degradation of surfactant components leads to impaired respiratory mechanics and loss of the air-blood barrier, causing widespread atelectasis.<xref ref-type="bibr" rid="article-147412.r9">[9]</xref><xref ref-type="bibr" rid="article-147412.r10">[10]</xref>&#x000a0;</p>
        <p>As phosgene's toxicity ensues, its degradation into HCl is also thought to worsen tissue insult. The combination of surfactant loss and a compromised air-blood barrier leads to pathognomonic noncardiogenic pulmonary edema, impairs gas exchange by increasing the diffusion distance for oxygen. As the blood-air barrier receives further insult, diffuse alveolar hemorrhage may occur. In severe cases, the fulminant interstitial edema may progress to acute respiratory distress syndrome (ARDS).<xref ref-type="bibr" rid="article-147412.r11">[11]</xref></p>
      </sec>
      <sec id="article-147412.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Phosgene is a hydrophobic (low water solubility) molecule that resists degradation into HCl and CO2 in the upper airways. For this reason, phosgene migrates to the lower airway units, including the alveolar sacs and respiratory bronchioles, where histopathologic changes occur. These changes may include the destruction of the alveolar epithelial cells and capillary endothelium characterized by infiltration of the alveolus with inflammatory cells and proteinaceous fluid. Fibrin accumulation with alveolar macrophages may be present in patients who survive the initial insult.</p>
      </sec>
      <sec id="article-147412.s7" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>Phosgene exists in the gaseous phase at room temperature. The severity of the disease has been previously proposed to follow Haber's law, which indicates predicted Toxicity by Inhalation Toxicity = Concentration x Time. Once inhaled, the concentration and duration of exposure predict the events' sequelae and the disease's progression.</p>
        <p>Symptom onset is inversely proportional to the concentration exposed; high concentrations of phosgene inhaled confer a more rapid onset of symptoms and a poorer prognosis. However, low doses of inhaled phosgene may present with few or no upper respiratory symptoms but may accumulate enough in the lower respiratory unit to cause delayed respiratory failure. The detection threshold in humans has been reported to be 0.125 ppm/ min. Concentrations exceeding 2 ppm/ min or more have been classified as immediately dangerous to life or health (IDLH) by the Centers for Disease Control and Prevention. At 1 - 3 ppm/ min, irritant effects may be expected. Below 50 ppm/ min, clinical pulmonary symptoms are not expected. Between 50- 150 ppm/ min, pulmonary irritation may be expected without manifest edema.<xref ref-type="bibr" rid="article-147412.r12">[12]</xref>&#x000a0;</p>
        <p>Exposures exceeding 150 ppm/ min should be expected to develop pulmonary edema.<xref ref-type="bibr" rid="article-147412.r13">[13]</xref>&#x000a0;Concentrations greater than 300 ppm/ min are likely to produce fatal pulmonary edema.<xref ref-type="bibr" rid="article-147412.r14">[14]</xref></p>
      </sec>
      <sec id="article-147412.s8" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>At lower concentrations, patients may not report the characteristic odor of phosgene, though the odor&#x000a0;is sharper and &#x0201c;suffocating&#x0201d; at higher concentrations. System review may reveal subjective findings such as headache, nausea, and fatigue. Irritant effects such as burning, lacrimation, eye redness, eye pain, pharyngitis, wheezing, and cough may be present.<xref ref-type="bibr" rid="article-147412.r3">[3]</xref><xref ref-type="bibr" rid="article-147412.r15">[15]</xref>&#x000a0;</p>
        <p>Uniquely, tobacco smokers may report an aversion to tobacco smoke following exposure to phosgene. Pulmonary and cardiovascular findings may include wheezing, choking sensation, chest tightness, dyspnea, and chest pain.<xref ref-type="bibr" rid="article-147412.r16">[16]</xref>&#x000a0;Symptom onset commonly occurs within 2&#x000a0;to 24 hours; however, due to phosgene&#x02019;s low water solubility, symptoms may be delayed past 24 hours. Case reports have documented delays of up to 72 hours and were provoked by exertion.</p>
        <p>Vital signs most frequently reveal tachypnea, hypotension, and decreased pulse oximetry, though it may not be evident early in the clinical course. Physical exam may reveal a productive cough with pink, frothy sputum, pharyngeal edema, or erythema with inspiratory and expiratory rhonchi. Wheezing may be appreciated during the auscultation of lung fields. Patients in distress may appear cyanotic. Significant concentrations of inhaled phosgene have been reported to induce rapid onset laryngospasm.</p>
      </sec>
      <sec id="article-147412.s9" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Patients should be referred to a health care facility for evaluation and monitoring if phosgene exposures exceed 50 ppm/ min, inhaled concentration is unknown, liquid phosgene exposure to the face or oropharynx, or respiratory symptoms. Vital signs, serial examinations, and laboratory and imaging studies monitor the progression of acute hypoxemic respiratory failure caused by phosgene ALI.&#x000a0;A complete blood count, chemistries, troponin, and brain natriuretic peptide (BNP) are also necessary.</p>
        <p>Though not specific, case studies have reported leukocytosis, hypokalemia, and hyponatremia in patients exhibiting phosgene toxicity. Serum troponin and BNP may be used when the diagnosis is unclear and is likely normal. Arterial blood gas measurements and chest radiographs should be trended if there are indications of pulmonary involvement. Characteristic findings may include fluffy bilateral opacities and hilar congestion. ECG often reveals sinus tachycardia, although the fulminant disease may reveal signs of right heart strain.</p>
      </sec>
      <sec id="article-147412.s10" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Decontaminate the patient during the initial evaluation if the emergency response system has not already performed it. Liquid phosgene may prolong inhalation exposure if it remains present on the clothing. Garments should be removed and double-bagged. Encourage the patient to remain calm if the inhaled concentration is suspected to be greater than 150 ppm/ min, for excessive activity or distress may exacerbate pulmonary edema.<xref ref-type="bibr" rid="article-147412.r17">[17]</xref>&#x000a0;</p>
        <p>Low-dose morphine or benzodiazepines may be used for anxiolysis. Airway, breathing, and circulation should be assessed during the initial evaluation. Patients should be started on noninvasive oxygen supplementation with pulse oximetry readings less than 92% or signs of respiratory distress. Recent animal studies have shown that noninvasive positive airway pressure (NIPPV) improves outcomes in those with and without pulmonary involvement.<xref ref-type="bibr" rid="article-147412.r18">[18]</xref><xref ref-type="bibr" rid="article-147412.r19">[19]</xref><xref ref-type="bibr" rid="article-147412.r20">[20]</xref>&#x000a0;</p>
        <p>Early NIPPV is recommended or should be considered in patients with exposures exceeding 150 ppm/min, unknown exposure, or liquid phosgene exposure to the face. Endotracheal intubation may be required following inadequate support with NIPPV, inability to protect the airway, or other contraindications to noninvasive ventilation techniques. There is insufficient evidence to support the use of corticosteroids in treating phosgene ALI. Despite this, their use is left to the discretion of the attending clinician.<xref ref-type="bibr" rid="article-147412.r21">[21]</xref><xref ref-type="bibr" rid="article-147412.r22">[22]</xref>&#x000a0;</p>
        <p>Extracorporeal membrane oxygenation (ECMO) has produced positive outcomes in those requiring prolonged ventilatory support, pulmonary edema refractory to ventilatory techniques, or management requiring unsafe ventilator settings.<xref ref-type="bibr" rid="article-147412.r23">[23]</xref>&#x000a0;Inhaled beta-adrenergic agonists may be used to treat bronchospasm.</p>
      </sec>
      <sec id="article-147412.s11" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Phosgene ALI should be included in the differential for pathologies characterized by hypoxia with evidence of central vascular congestion with or without pulmonary infiltrates. Consider pulmonary contusion, infectious pneumonia, aspiration pneumonitis, cardiogenic pulmonary edema (eg, acute decompensated congestive heart failure), or pulmonary hemorrhage.</p>
        <p>History, physical examination, and laboratory analysis differentiate acute cardiogenic pulmonary edema from contusion. Consider infectious pneumonia in those with pyrexia, leukocytosis, and a productive cough. Historical features and physical examination may differentiate aspiration pneumonitis, but management additions such as antibiotics&#x000a0;are likely included.</p>
      </sec>
      <sec id="article-147412.s12" sec-type="Pertinent Studies and Ongoing Trials">
        <title>Pertinent Studies and Ongoing Trials</title>
        <p>Current research suggests prophylactic NIPPV may mitigate lung injury before clinical signs of pulmonary toxicity and may reduce mortality based on animal studies.<xref ref-type="bibr" rid="article-147412.r18">[18]</xref><xref ref-type="bibr" rid="article-147412.r19">[19]</xref>&#x000a0;Ulinastatin is a serine protease inhibitor that has shown theoretical promise in animal studies by decreasing focused inflammatory markers in acute pneumonitis.<xref ref-type="bibr" rid="article-147412.r24">[24]</xref>&#x000a0;In&#x000a0;1 animal study, Tomelukast, a leukotriene receptor antagonist, prevented progression to ARDS.<xref ref-type="bibr" rid="article-147412.r11">[11]</xref>&#x000a0;</p>
        <p>Other anti-inflammatory medical therapies showing theoretical promise include nitrous oxide (NO) inhibitors, melatonin, and angiopoietin-1 (Ang1) inhibitors. Antioxidative strategies are also being investigated. Nebulized N-acetylcysteine (NAC) is being investigated for its potential as a glutathione (GSH) regenerator. However, studies are conflicting, and further research is needed to elucidate the proper timing of therapy. One study suggests pulmonary edema may render nebulized NAC inaccessible.<xref ref-type="bibr" rid="article-147412.r7">[7]</xref>&#x000a0;</p>
        <p>Intravenous NAC appears to improve systemic oxygenation but does not prevent progression to respiratory failure. Ibuprofen (IBU) is readily available and has shown positive outcomes when administered pre- and post-exposure. Still, the utility of pre-exposure use is not practical as most phosgene exposures are not anticipated. Supportive measures such as lung protective ventilation characterized by low tidal volume, high positive end-expiratory pressure, and high FiO2 are recommended for phosgene ALI.<xref ref-type="bibr" rid="article-147412.r20">[20]</xref></p>
      </sec>
      <sec id="article-147412.s13" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Patients with a known phosgene exposure of less than 50 mcg/ min are cleared from evaluation by a healthcare facility. Patients with exposures of 50&#x000a0;to 150 mcg/min, unknown exposure concentration, or respiratory symptoms should seek evaluation at a healthcare facility.<xref ref-type="bibr" rid="article-147412.r13">[13]</xref></p>
        <p>After evaluation by a healthcare professional, patients with no signs of toxicity or pulmonary edema may be discharged with precautions after 8 hours of observation. Additional medical monitoring is warranted before discharge if the discussed criteria are not met after 8 hours. Severe injury is predicted by the onset of pulmonary edema within 2&#x000a0;to 6 hours. Patients&#x000a0;who develop pulmonary edema should be considered for transfer to an ECMO facility, given the potential for refractory ARDS. Assuming survival from the initial insult, phosgene toxicity has a favorable prognosis, with a return to baseline expected within&#x000a0;1 to&#x000a0;2 years.</p>
      </sec>
      <sec id="article-147412.s14" sec-type="Complications">
        <title>Complications</title>
        <p>Patients who survive the initial insult have been reported to experience increased dyspnea on exertion and poor exercise tolerance for several months. A history of smoking worsens the prognosis of individuals with phosgene inhalation injury.</p>
      </sec>
      <sec id="article-147412.s15" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>Following hospitalization, recovery should include referral to occupational health and regular pulmonary function testing to monitor healing.</p>
      </sec>
      <sec id="article-147412.s16" sec-type="Consultations">
        <title>Consultations</title>
        <p>Patients with measurable phosgene exposure, unknown exposure, or pulmonary findings should be observed or managed in a hospital setting. If the diagnostic evaluation is consistent with acute or impending hypoxic respiratory failure, then consultation with a critical care specialist is appropriate, as well as consideration regarding the potential benefit of ECMO. The step-down unit&#x000a0;in intensive care is appropriate with stable diagnostics and trending improvement. Patients may be admitted to floor-level management after at least 6 hours of stable observation. If there are signs of ophthalmic injury, consult an ophthalmologist.</p>
      </sec>
      <sec id="article-147412.s17" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Phosgene is primarily an occupational exposure. Workers in phosgene industries use phosgene badges, which may be the only exposure indicator. Therefore, the patient care team should inquire about 1. Those exposed to phosgene should wear badges as close to the inhalation zone as possible. They should only be used as estimates as they cannot reflect inhaled concentration. Thus, clinical judgment is paramount.</p>
        <p>The Environmental Protection Agency (EPA) has measured air samples in California and identified concentrations not exceeding 31.8 parts per trillion (ppt) in the Los Angeles basin. The Occupational Safety and Health Administration, The National Institute for Occupational Safety and Health (NIOSH), and the American Conference of Governmental Industrial Hygienists (ACGIH) have recommended that exposure limits be no greater than 0.1 ppm. This is particularly useful in settings where phosgene badges are utilized.&#x000a0;</p>
      </sec>
      <sec id="article-147412.s18" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Initiate NIPPV within 1 hour of evaluation of phosgene toxicity with pulmonary involvement.<xref ref-type="bibr" rid="article-147412.r18">[18]</xref><xref ref-type="bibr" rid="article-147412.r20">[20]</xref>&#x000a0;Consider lung protective ventilation when managing phosgene ARDS to prevent iatrogenic trauma from mechanical ventilation and encourage healthy lung mechanics. In practice, maintain a high PEEP and low tidal volumes. Deep sedation and neuromuscular blockade can assist with ventilator compliance.&#x000a0;</p>
      </sec>
      <sec id="article-147412.s19" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Successful management involves the coordination of emergency physicians and other clinicians, intensivists, pulmonologists, pharmacists, toxicologists, and nurses operating as an interprofessional healthcare team. Coordination with&#x000a0;clinical&#x000a0;staff is critical to obtain timely analyses and identify clinical deterioration. Nurses can monitor the patient, letting the clinicians know if they note any deterioration in the patient's status. While drug&#x000a0;therapy plays a minor role in managing phosgene toxicity, pharmacists&#x000a0;can provide the needed medications to manage the case and perform medication reconciliation.</p>
        <p>Though insidious, phosgene pneumonitis can emerge quickly, so timely gathering of critical data points by&#x000a0;clinical staff can ensure providers are prepared for a failing airway. Intensivists&#x000a0;are involved with phosgene toxicity&#x000a0;with associated respiratory failure and should be consulted early in the disease. Emergency clinicians should recognize progressive hypoxia and maintain ABCs while consulting toxicologists for accurate diagnosis and proper management. All interprofessional team members must communicate openly and keep updated and accurate patient records so that all caregivers have the same information to base clinical decisions.&#x000a0;</p>
        <p>All interprofessional team members should&#x000a0;be open to inclusivity concepts regarding patients and fellow team members. This approach, combined with interprofessional care, yields optimal patient results.</p>
      </sec>
      <sec id="article-147412.s20">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=147412&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=147412">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/wilderness-and-environmental/phosgene-toxicity/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=147412">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/147412/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=147412">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-147412.s21">
        <title>References</title>
        <ref id="article-147412.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nicholson-Roberts</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>Phosgene use in World War 1 and early evaluations of pathophysiology.</article-title>
            <source>J R Army Med Corps</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>165</volume>
            <issue>3</issue>
            <fpage>183</fpage>
            <page-range>183-187</page-range>
            <pub-id pub-id-type="pmid">30355742</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cao</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Phosgene-Induced acute lung injury: Approaches for mechanism-based treatment strategies.</article-title>
            <source>Front Immunol</source>
            <year>2022</year>
            <volume>13</volume>
            <fpage>917395</fpage>
            <pub-id pub-id-type="pmid">35983054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Meng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Mechanism of Phosgene-Induced Acute Lung Injury and Treatment Strategy.</article-title>
            <source>Int J Mol Sci</source>
            <year>2021</year>
            <month>Oct</month>
            <day>10</day>
            <volume>22</volume>
            <issue>20</issue>
            <pub-id pub-id-type="pmid">34681591</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gutch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Agrawal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Consul</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Acute accidental phosgene poisoning.</article-title>
            <source>BMJ Case Rep</source>
            <year>2012</year>
            <month>Apr</month>
            <day>02</day>
            <volume>2012</volume>
            <pub-id pub-id-type="pmid">22602834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Recent Advances in the Development of Chromophore-Based Chemosensors for Nerve Agents and Phosgene.</article-title>
            <source>ACS Sens</source>
            <year>2018</year>
            <month>Jan</month>
            <day>26</day>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>27</fpage>
            <page-range>27-43</page-range>
            <pub-id pub-id-type="pmid">29231710</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Qiu</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>YT</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>[Investigation and analysis of 7 cases of acute lung injury caused by a welding operation].</article-title>
            <source>Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi</source>
            <year>2019</year>
            <month>Jan</month>
            <day>20</day>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>60</fpage>
            <page-range>60-62</page-range>
            <pub-id pub-id-type="pmid">30884593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rendell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fairhall</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rutter</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Auton</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Perrott</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jugg</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Assessment of N-acetylcysteine as a therapy for phosgene-induced acute lung injury.</article-title>
            <source>Toxicol Lett</source>
            <year>2018</year>
            <month>Jun</month>
            <day>15</day>
            <volume>290</volume>
            <fpage>145</fpage>
            <page-range>145-152</page-range>
            <pub-id pub-id-type="pmid">29574134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guastadisegni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Guidoni</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Balduzzi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Viti</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Di Consiglio</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vittozzi</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Characterization of a phospholipid adduct formed in Sprague Dawley rats by chloroform metabolism: NMR studies.</article-title>
            <source>J Biochem Mol Toxicol</source>
            <year>1998</year>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>93</fpage>
            <page-range>93-102</page-range>
            <pub-id pub-id-type="pmid">9443066</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Pauluhn</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Phosgene-induced acute lung injury (ALI): differences from chlorine-induced ALI and attempts to translate toxicology to clinical medicine.</article-title>
            <source>Clin Transl Med</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <pub-id pub-id-type="pmid">28577109</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Summerhill</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Hoyle</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Jordt</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Jugg</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Matalon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Patterson</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Prezant</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Sciuto</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Svendsen</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Veress</surname>
                <given-names>LA</given-names>
              </name>
              <collab>ATS Terrorism and Inhalational Disasters Section of the Environmental, Occupational, and Population Health Assembly</collab>
            </person-group>
            <article-title>An Official American Thoracic Society Workshop Report: Chemical Inhalational Disasters. Biology of Lung Injury, Development of Novel Therapeutics, and Medical Preparedness.</article-title>
            <source>Ann Am Thorac Soc</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>1060</fpage>
            <page-range>1060-1072</page-range>
            <pub-id pub-id-type="pmid">28418689</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guo</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Michael</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Sciuto</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Ghio</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Adkinson</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Gurtner</surname>
                <given-names>GH</given-names>
              </name>
            </person-group>
            <article-title>Mechanism of phosgene-induced lung toxicity: role of arachidonate mediators.</article-title>
            <source>J Appl Physiol (1985)</source>
            <year>1990</year>
            <month>Nov</month>
            <volume>69</volume>
            <issue>5</issue>
            <fpage>1615</fpage>
            <page-range>1615-22</page-range>
            <pub-id pub-id-type="pmid">2125593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Pauluhn</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Phosgene-induced lung edema: Comparison of clinical criteria for increased extravascular lung water content with postmortem lung gravimetry and lavage-protein in rats and dogs.</article-title>
            <source>Toxicol Lett</source>
            <year>2019</year>
            <month>May</month>
            <day>01</day>
            <volume>305</volume>
            <fpage>32</fpage>
            <page-range>32-39</page-range>
            <pub-id pub-id-type="pmid">30668997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Plahovinsak</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Knostman</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Segal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Babin</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Characterization of a nose-only inhaled phosgene acute lung injury mouse model.</article-title>
            <source>Inhal Toxicol</source>
            <year>2015</year>
            <volume>27</volume>
            <issue>14</issue>
            <fpage>832</fpage>
            <page-range>832-40</page-range>
            <pub-id pub-id-type="pmid">26671199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Diller</surname>
                <given-names>WF</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis of phosgene poisoning.</article-title>
            <source>Toxicol Ind Health</source>
            <year>1985</year>
            <month>Oct</month>
            <volume>1</volume>
            <issue>2</issue>
            <fpage>7</fpage>
            <page-range>7-15</page-range>
            <pub-id pub-id-type="pmid">3842189</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Borak</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Diller</surname>
                <given-names>WF</given-names>
              </name>
            </person-group>
            <article-title>Phosgene exposure: mechanisms of injury and treatment strategies.</article-title>
            <source>J Occup Environ Med</source>
            <year>2001</year>
            <month>Feb</month>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>110</fpage>
            <page-range>110-9</page-range>
            <pub-id pub-id-type="pmid">11227628</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grainge</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Management of phosgene-induced acute lung injury.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>48</volume>
            <issue>6</issue>
            <fpage>497</fpage>
            <page-range>497-508</page-range>
            <pub-id pub-id-type="pmid">20849339</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matthay</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Esmon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Coller</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Doerschuk</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Floros</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gimbrone</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hubmayr</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Leppert</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Matalon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Munford</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Parsons</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Slutsky</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Tracey</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gail</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Harabin</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2003</year>
            <month>Apr</month>
            <day>01</day>
            <volume>167</volume>
            <issue>7</issue>
            <fpage>1027</fpage>
            <page-range>1027-35</page-range>
            <pub-id pub-id-type="pmid">12663342</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Graham</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fairhall</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rutter</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Auton</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rendell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Perrott</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Jugg</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Continuous positive airway pressure: An early intervention to prevent phosgene-induced acute lung injury.</article-title>
            <source>Toxicol Lett</source>
            <year>2018</year>
            <month>Sep</month>
            <day>01</day>
            <volume>293</volume>
            <fpage>120</fpage>
            <page-range>120-126</page-range>
            <pub-id pub-id-type="pmid">29104014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Rosenbruch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pauluhn</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Effect of PEEP on phosgene-induced lung edema: pilot study on dogs using protective ventilation strategies.</article-title>
            <source>Exp Toxicol Pathol</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>67</volume>
            <issue>2</issue>
            <fpage>109</fpage>
            <page-range>109-16</page-range>
            <pub-id pub-id-type="pmid">25467748</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parkhouse</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Jugg</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Harban</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Platt</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kenward</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Jenner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Protective ventilation strategies in the management of phosgene-induced acute lung injury.</article-title>
            <source>Mil Med</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>172</volume>
            <issue>3</issue>
            <fpage>295</fpage>
            <page-range>295-300</page-range>
            <pub-id pub-id-type="pmid">17436775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pauluhn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tr&#x000fc;bel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Corticosteroids found ineffective for phosgene-induced acute lung injury in rats.</article-title>
            <source>Toxicol Lett</source>
            <year>2014</year>
            <month>Aug</month>
            <day>17</day>
            <volume>229</volume>
            <issue>1</issue>
            <fpage>85</fpage>
            <page-range>85-92</page-range>
            <pub-id pub-id-type="pmid">24910984</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pauluhn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tr&#x000fc;bel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Single high-dose dexamethasone and sodium salicylate failed to attenuate phosgene-induced acute lung injury in rats.</article-title>
            <source>Toxicology</source>
            <year>2014</year>
            <month>Jan</month>
            <day>06</day>
            <volume>315</volume>
            <fpage>17</fpage>
            <page-range>17-23</page-range>
            <pub-id pub-id-type="pmid">24280380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>He</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>[Extracorporeal membrane oxygenation for acute respiratory distress syndrome caused by acute phosgene poisoning: a report of 4 cases].</article-title>
            <source>Zhonghua Wei Zhong Bing Ji Jiu Yi Xue</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>232</fpage>
            <page-range>232-235</page-range>
            <pub-id pub-id-type="pmid">30827316</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147412.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gan</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Ulinastatin reduces pathogenesis of phosgene-induced acute lung injury in rats.</article-title>
            <source>Toxicol Ind Health</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>30</volume>
            <issue>9</issue>
            <fpage>785</fpage>
            <page-range>785-93</page-range>
            <pub-id pub-id-type="pmid">23075575</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
